Casdin Capital, LLC Pacific Biosciences Of California, Inc. Transaction History
Casdin Capital, LLC
- $1.16 Billion
- Q2 2024
A detailed history of Casdin Capital, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 1,035,859 shares of PACB stock, worth $2.05 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
1,035,859
Previous 1,035,859
-0.0%
Holding current value
$2.05 Million
Previous $1.42 Million
-0.0%
% of portfolio
0.12%
Previous 0.12%
Shares
5 transactions
Others Institutions Holding PACB
# of Institutions
255Shares Held
234MCall Options Held
1.02MPut Options Held
965K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.2MShares$65.8 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA26MShares$51.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$46.7 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$46.3 Million5.63% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V816.7MShares$33.1 Million0.4% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $445M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...